Comparative Results: Clinical studies, such as the SURPASS and SURMOUNT programs, have indicated that Mounjaro may lead to greater fat loss than Ozempic
Activity Overview Intended Audience: Hepatologists, gastroenterologists, primary care physicians, endocrinologists (including diabetologists), and their clinical teams (NPs, PAs, nurses, and pharmacists) caring for patients with MASH Therapeutic strategies that address both metabolic dysfunction-associated steatohepatitis (MASH) and its underlying metabolic drivers are increasingly important given it frequent coexistence with conditions such as obesity, type 2 diabetes, and dyslipidemia
However, we did occasionally see the -cells located in the middle of a subset of islets appearing as a double-stained faint glucagon and low-insulin protein (Fig
But closer attention makes sense if meals are skipped regularly, protein-rich foods are barely tolerated, drinking becomes difficult, or weight loss progresses very quickly
Avoid large, heavy meals on injection day